Filtros : "EVENTO ADVERSO A MEDICAMENTO" "BRASIL" Limpar

Filtros



Refine with date range


  • Source: Clinical lymphoma myeloma & leukemia. Unidade: FM

    Subjects: LEUCEMIA MIELOIDE AGUDA, EVENTO ADVERSO A MEDICAMENTO, MORTALIDADE, FARMACOTERAPIA, BRASIL

    Acesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      SILVA JUNIOR, Wellington Fernandes da e VELLOSO, Elvira D. R. P. e ROCHA, Vanderson. Treating Adult Acute Lymphoblastic Leukemia in Brazil-Increased Early Mortality Using a German Multicenter Acute Lymphoblastic Leukemia-based regimen. Clinical lymphoma myeloma & leukemia, v. 18, n. 6, p. E255-E259, 2018Tradução . . Disponível em: https://doi.org/10.1016/j.clml.2018.03.001. Acesso em: 27 set. 2024.
    • APA

      Silva Junior, W. F. da, Velloso, E. D. R. P., & Rocha, V. (2018). Treating Adult Acute Lymphoblastic Leukemia in Brazil-Increased Early Mortality Using a German Multicenter Acute Lymphoblastic Leukemia-based regimen. Clinical lymphoma myeloma & leukemia, 18( 6), E255-E259. doi:10.1016/j.clml.2018.03.001
    • NLM

      Silva Junior WF da, Velloso EDRP, Rocha V. Treating Adult Acute Lymphoblastic Leukemia in Brazil-Increased Early Mortality Using a German Multicenter Acute Lymphoblastic Leukemia-based regimen [Internet]. Clinical lymphoma myeloma & leukemia. 2018 ; 18( 6): E255-E259.[citado 2024 set. 27 ] Available from: https://doi.org/10.1016/j.clml.2018.03.001
    • Vancouver

      Silva Junior WF da, Velloso EDRP, Rocha V. Treating Adult Acute Lymphoblastic Leukemia in Brazil-Increased Early Mortality Using a German Multicenter Acute Lymphoblastic Leukemia-based regimen [Internet]. Clinical lymphoma myeloma & leukemia. 2018 ; 18( 6): E255-E259.[citado 2024 set. 27 ] Available from: https://doi.org/10.1016/j.clml.2018.03.001
  • Source: Breast cancer. Unidade: FM

    Subjects: NEOPLASIAS MAMÁRIAS, ANTINEOPLÁSICOS, EVENTO ADVERSO A MEDICAMENTO, BRASIL

    Acesso à fonteAcesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      SANTANA, Iuri A. et al. Feasibility of two schedules of weekly paclitaxel in HER2-negative early breast cancer in a Brazilian community setting. Breast cancer, v. 23, n. 2, p. 261-265, 2016Tradução . . Disponível em: http://link.springer.com/article/10.1007%2Fs12282-014-0564-9. Acesso em: 27 set. 2024.
    • APA

      Santana, I. A., Oliveira, J. A., Lima, J. M. da S., Testa, L., Piato, J. R. M., Hoff, P. M., & Mano, M. S. (2016). Feasibility of two schedules of weekly paclitaxel in HER2-negative early breast cancer in a Brazilian community setting. Breast cancer, 23( 2), 261-265. doi:10.1007/s12282-014-0564-9
    • NLM

      Santana IA, Oliveira JA, Lima JM da S, Testa L, Piato JRM, Hoff PM, Mano MS. Feasibility of two schedules of weekly paclitaxel in HER2-negative early breast cancer in a Brazilian community setting [Internet]. Breast cancer. 2016 ; 23( 2): 261-265.[citado 2024 set. 27 ] Available from: http://link.springer.com/article/10.1007%2Fs12282-014-0564-9
    • Vancouver

      Santana IA, Oliveira JA, Lima JM da S, Testa L, Piato JRM, Hoff PM, Mano MS. Feasibility of two schedules of weekly paclitaxel in HER2-negative early breast cancer in a Brazilian community setting [Internet]. Breast cancer. 2016 ; 23( 2): 261-265.[citado 2024 set. 27 ] Available from: http://link.springer.com/article/10.1007%2Fs12282-014-0564-9

Digital Library of Intellectual Production of Universidade de São Paulo     2012 - 2024